LH logo

LH Stock Overview

Profile

Full Name:

Labcorp Holdings Inc.

Sector:

Healthcare

Country:

United States

IPO:

March 29, 1990

Indexes:

Description:

Laboratory Corporation of America Holdings is a global company in the field of natural sciences. It provides comprehensive clinical laboratory services and drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) segments. The company was founded in 1971, headquartered in Burlington, North Carolina. LabCorp provides diagnostic, drug, and technology solutions for more than 160 million clients per year, or over 3 million per week. The company also supports clinical trials in approximately 100 countries through its industry-leading central laboratories, preclinical and clinical development, generating more safety and efficacy data to support drug approvals than any other company.

Key Details

Price

$252.65

Annual Revenue

$12.16 B(+2.51% YoY)

Annual EPS

$4.77(-65.86% YoY)

Beta

0.44

Events Calendar

Earnings

Next earnings date:

Feb 6, 2025

Recent quarterly earnings:

Oct 24, 2024

Recent annual earnings:

Feb 6, 2025
Dividend

Next ex-dividend date:

Feb 27, 2025

Recent ex-dividend date:

Nov 26, 2024
Splits

Next split:

N/A

Recent split:

Jul 3, 2023

Analyst ratings

Recent major analysts updates

Feb 3, 25 Barclays
Equal-Weight
Jan 28, 25 UBS
Buy
Jan 7, 25 Evercore ISI Group
Outperform
Dec 17, 24 Morgan Stanley
Overweight
Dec 13, 24 B of A Securities
Buy
Dec 10, 24 Jefferies
Buy
Oct 30, 24 HSBC
Buy
Oct 28, 24 Piper Sandler
Neutral
Oct 25, 24 Barclays
Equal-Weight
Oct 25, 24 Baird
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript
Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript
Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript
LH
seekingalpha.comFebruary 6, 2025

Labcorp Holdings Inc. (NYSE:LH) will hold its Q4 2024 Earnings Conference Call on February 6, 2025, at 9:00 AM ET. The call will feature company representatives including Christian O'Donnell, Adam Schechter, and Julia Wang, along with various participants from different financial firms. The operator will welcome everyone and provide instructions for the call.

Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
LH
benzinga.comFebruary 6, 2025

On Thursday, Laboratory Corp (NYSE: LH) announced its adjusted earnings per share for the fourth quarter of 2024, which was $3.45. This is an increase from $3.30 the previous year and surpasses the expected figure of $3.39.

Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Labcorp (LH) Q4 Earnings: A Look at Key Metrics
LH
zacks.comFebruary 6, 2025

While Labcorp's (LH) revenue and earnings per share (EPS) provide insight into its performance for the quarter ending December 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.

Labcorp (LH) Q4 Earnings and Revenues Surpass Estimates
Labcorp (LH) Q4 Earnings and Revenues Surpass Estimates
Labcorp (LH) Q4 Earnings and Revenues Surpass Estimates
LH
zacks.comFebruary 6, 2025

Labcorp (LH) reported quarterly earnings of $3.45 per share, which is higher than the Zacks Consensus Estimate of $3.40 per share. This is an increase compared to last year's earnings of $3.30 per share.

Labcorp Set to Report Q4 Earnings: What's in Store for the Stock?
Labcorp Set to Report Q4 Earnings: What's in Store for the Stock?
Labcorp Set to Report Q4 Earnings: What's in Store for the Stock?
LH
zacks.comJanuary 31, 2025

In the last quarter of 2024, LH is expected to have experienced significant growth in its diagnostics and biopharma laboratory services.

Why Labcorp (LH) is Poised to Beat Earnings Estimates Again
Why Labcorp (LH) is Poised to Beat Earnings Estimates Again
Why Labcorp (LH) is Poised to Beat Earnings Estimates Again
LH
zacks.comJanuary 9, 2025

Labcorp (LH) has a strong track record of surprising with its earnings and currently has the right factors in place that suggest it may exceed expectations in its upcoming quarterly report.

LABCORP DECLARES QUARTERLY DIVIDEND
LABCORP DECLARES QUARTERLY DIVIDEND
LABCORP DECLARES QUARTERLY DIVIDEND
LH
prnewswire.comJanuary 8, 2025

BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a worldwide leader in advanced laboratory services, has announced that its Board of Directors has approved a cash dividend of $0.72 for each share of common stock.

Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
LH
prnewswire.comJanuary 8, 2025

BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a top provider of advanced laboratory services, is set to announce its financial results for the fourth quarter of 2024 before the market opens on Thursday, February 6, 2025.

Is Labcorp (LH) Stock Undervalued Right Now?
Is Labcorp (LH) Stock Undervalued Right Now?
Is Labcorp (LH) Stock Undervalued Right Now?
LH
zacks.comJanuary 3, 2025

At Zacks, we concentrate on the reliable Zacks Rank system, which highlights earnings estimates and changes in those estimates to identify excellent stocks. At the same time, we keep an eye on the most recent trends in value, growth, and momentum to support our top selections.

Should You Retain Labcorp Stock in Your Portfolio Right Now?
Should You Retain Labcorp Stock in Your Portfolio Right Now?
Should You Retain Labcorp Stock in Your Portfolio Right Now?
LH
zacks.comJanuary 3, 2025

Investors are becoming more positive about LH because of its emphasis on areas with high growth potential and its strategic collaborations.

FAQ

  • What is the ticker symbol for Laboratory Corporation of America Holdings?
  • Does Laboratory Corporation of America Holdings pay dividends?
  • What sector is Laboratory Corporation of America Holdings in?
  • What industry is Laboratory Corporation of America Holdings in?
  • What country is Laboratory Corporation of America Holdings based in?
  • When did Laboratory Corporation of America Holdings go public?
  • Is Laboratory Corporation of America Holdings in the S&P 500?
  • Is Laboratory Corporation of America Holdings in the NASDAQ 100?
  • Is Laboratory Corporation of America Holdings in the Dow Jones?
  • When was Laboratory Corporation of America Holdings's last earnings report?
  • When does Laboratory Corporation of America Holdings report earnings?
  • Should I buy Laboratory Corporation of America Holdings stock now?

What is the ticker symbol for Laboratory Corporation of America Holdings?

The ticker symbol for Laboratory Corporation of America Holdings is NYSE:LH

Does Laboratory Corporation of America Holdings pay dividends?

Yes, Laboratory Corporation of America Holdings pays dividends. The last payment was $0.72, with an ex-dividend date on November 26, 2024

What sector is Laboratory Corporation of America Holdings in?

Laboratory Corporation of America Holdings is in the Healthcare sector

What industry is Laboratory Corporation of America Holdings in?

Laboratory Corporation of America Holdings is in the Diagnostics & Research industry

What country is Laboratory Corporation of America Holdings based in?

Laboratory Corporation of America Holdings is headquartered in United States

When did Laboratory Corporation of America Holdings go public?

Laboratory Corporation of America Holdings's initial public offering (IPO) was on March 29, 1990

Is Laboratory Corporation of America Holdings in the S&P 500?

Yes, Laboratory Corporation of America Holdings is included in the S&P 500 index

Is Laboratory Corporation of America Holdings in the NASDAQ 100?

No, Laboratory Corporation of America Holdings is not included in the NASDAQ 100 index

Is Laboratory Corporation of America Holdings in the Dow Jones?

No, Laboratory Corporation of America Holdings is not included in the Dow Jones index

When was Laboratory Corporation of America Holdings's last earnings report?

Laboratory Corporation of America Holdings's most recent earnings report was on Oct 24, 2024

When does Laboratory Corporation of America Holdings report earnings?

The next expected earnings date for Laboratory Corporation of America Holdings is Feb 6, 2025

Should I buy Laboratory Corporation of America Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions